A Ruiz-Alejos, RM Carrillo-Larco… - Revista peruana de …, 2022 - SciELO Public Health
Objetivo. Determinar la prevalencia e incidencia de hipertensión arterial, y la prevalencia de diagnóstico previo de hipertensión arterial (autorreportado) en población general adulta del …
SJ Pickersgill, WT Msemburi, L Cobb, N Ide… - Nature medicine, 2022 - nature.com
As the leading cause of death worldwide, cardiovascular diseases (CVDs) present major challenges for health systems. In this study, we analyzed the effects of better population …
K Kario, Y Yokoi, K Okamura, M Fujihara… - Hypertension …, 2022 - nature.com
Renal denervation is a promising new non-pharmacological treatment for resistant hypertension. However, there is a lack of data from Asian patients. The REQUIRE trial …
Background Hypertension is the most important cardiovascular risk factor in India, and representative studies of middle-aged and older Indian adults have been lacking. Our …
Background The influence of urbanicity on hypertension prevalence remains poorly understood. We conducted a systematic review and meta-analysis to assess the difference …
In this study, the oxidative degradation of losartan (LOS), a widely administered medicine for high blood pressure by heat-activated persulfate was investigated. Increased temperature …
There are 22 countries in the Eastern Mediterranean Region (EMR) expanding from Morocco in the west to Pakistan and Afghanistan in the east, containing a population of …
H Xu, S Li, YS Liu - Signal Transduction and Targeted Therapy, 2022 - nature.com
Aging-induced alternations of vasculature structures, phenotypes, and functions are key in the occurrence and development of vascular aging-related diseases. Multiple molecular and …
Y Ogoyama, K Tada, M Abe, S Nanto, H Shibata… - Hypertension …, 2022 - nature.com
The efficacy of renal denervation has been controversial, but recent randomized sham- controlled trials demonstrated significant blood pressure reductions after renal denervation …